GlassScriptPhysician profile
Hillary N Flaherty
NPI 1194079590
$9,257.93
in general payments reported to CMS, 2019-2025
72 companies · $3,599 in 2025
The $3,599 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $758 · 2023: $2,197 · 2024: $2,604 · 2025: $3,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,099 · Education: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,098.62 |
| Education | $301.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $924.17 | 2022-2025 | Tagrisso, Lynparza, Calquence |
| Novartis Pharmaceuticals Corporation | $610.92 | 2022-2025 | |
| Pfizer INC. | $506.32 | 2023-2025 | |
| Astellas Pharma US INC | $492.28 | 2023-2025 | Padcev, Xospata, Xtandi |
| Merck Sharp & Dohme LLC | $447.16 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $401.38 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Incyte Corporation | $382.42 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Ipsen Biopharmaceuticals, INC | $366.67 | 2022-2025 | Onivyde, Somatuline Depot, Tazverik |
| Eisai INC. | $296.28 | 2022-2025 | |
| Genentech USA, INC. | $258.95 | 2022-2025 | Tecentriq, Polivy, Lunsumio |
| Takeda Pharmaceuticals U.S.A., INC. | $215.75 | 2023-2025 | Fruzaqla, Vpriv, Alunbrig |
| Celgene Corporation | $211.67 | 2022-2025 | Reblozyl, Pomalyst, Opdivo |
| Seagen INC. | $201.08 | 2021-2023 | Tivdak |
| Gilead Sciences, INC. | $196.53 | 2022-2025 | Trodelvy |
| Genzyme Corporation | $195.64 | 2022-2025 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.16 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.49 | 2023-2025 | |
| Amgen INC. | $162.03 | 2023-2025 | Imdelltra (Amg757), Lumakras, Nplate |
| Sobi, INC | $144.46 | 2024-2025 | |
| Emd Serono, INC. | $142.42 | 2023-2025 | Bavencio |
| E.R. Squibb & Sons, L.L.C. | $141.43 | 2022-2025 | Opdivo, Opdualag |
| Lilly USA, LLC | $135.31 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Taiho Oncology, INC. | $130.81 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $120.40 | 2022-2025 | Monoferric |
| Daiichi Sankyo INC. | $118.72 | 2022-2025 | Enhertu, Injectafer, Vanflyta |
| Karyopharm Therapeutics INC. | $117.66 | 2022-2025 | Xpovio |
| Regeneron Healthcare Solutions, INC. | $112.59 | 2023-2025 | Libtayo, Lynozyfic |
| Sanofi-Aventis U.S. LLC | $99.99 | 2023 | |
| Servier Pharmaceuticals LLC | $94.95 | 2022-2025 | |
| Puma Biotechnology, INC. | $91.51 | 2022-2025 | |
| Adaptive Biotechnologies Corporation | $79.56 | 2022-2024 | Clonoseq |
| Jazz Pharmaceuticals INC. | $75.09 | 2022-2025 | |
| Beigene USA, INC. | $70.81 | 2023-2024 | Brukinsa |
| Pharmacyclics LLC, An Abbvie Company | $67.09 | 2022-2023 | Imbruvica |
| Mirati Therapeutics, INC. | $64.37 | 2023-2024 | Krazati |
| G1 Therapeutics, INC. | $60.74 | 2022-2023 | Cosela |
| Legend Biotech USA INC. | $58.32 | 2024-2025 | Carvykti |
| Stemline Therapeutics INC. | $54.66 | 2024-2025 | Orserdu, Elzonris |
| Alexion Pharmaceuticals, INC. | $54.51 | 2025 | Ultomiris |
| Novocure INC. | $52.41 | 2024-2025 | Optune Lua (Novottf-200t), Optune Gio |
| Beone Medicines USA, INC. | $49.12 | 2025 | Brukinsa, Tevimbra |
| Acrotech Biopharma INC. | $48.52 | 2023-2025 | Beleodaq |
| Azurity Pharmaceuticals, INC. | $48.28 | 2025 | Danziten, Vivimusta |
| Genmab U.S., INC. | $47.54 | 2023-2025 | Epkinly |
| Rigel Pharmaceuticals, INC. | $45.76 | 2022-2024 | Rezlidhia, Tavalisse |
| Tersera Therapeutics LLC | $45.31 | 2023-2025 | Xermelo, Zoladex |
| Accord Healthcare, INC. | $44.64 | 2025 | |
| Deciphera Pharmaceuticals INC. | $42.32 | 2024-2025 | Qinlock, Romvimza, Tgct |
| Caris Mpi, INC. | $39.61 | 2025 | Mi Cancer Seek |
| Iovance Biotherapeutics, INC. | $39.38 | 2025 | Amtagvi |
| Array Biopharma INC | $32.65 | 2023-2025 | Lorbrena, Braftovi, Mektovi |
| Cumberland Pharmaceuticals, INC. | $32.39 | 2024-2025 | Sancuso |
| Adc Therapeutics America, INC. | $31.61 | 2023-2025 | |
| Blue Earth Diagnostics | $28.10 | 2023 | |
| Kite Pharma, INC. | $25.32 | 2022 | |
| Kyowa Kirin, INC. | $24.06 | 2024 | Poteligeo |
| Syndax Pharmaceuticals, INC. | $22.80 | 2025 | |
| Exelixis INC. | $22.36 | 2023 | Cabometyx |
| Cti Biopharma Corp. | $22.19 | 2023 | Vonjo |
| Immunocore Limited | $20.96 | 2025 | Kimmtrak |
| Organon LLC | $20.64 | 2025 | Nexplanon |
| Foundation Medicine, INC. | $19.47 | 2022 | |
| Blueprint Medicines Corporation | $19.26 | 2025 | Ayvakit |
| Janssen Pharmaceuticals, INC | $19.00 | 2023 | Xarelto |
| Cycle Pharmaceuticals INC | $18.91 | 2025 | Phyrago |
| Morphosys, US INC. | $18.61 | 2023 | Monjuvi |
| Geron Corporation | $18.50 | 2024 | Rytelo |
| Agios Pharmaceuticals, INC. | $18.13 | 2025 | Pyrukynd |
| Sumitomo Pharma America, INC. | $17.47 | 2023 | Orgovyx |
| Coherus Oncology, INC. | $17.30 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.18 | 2025 | |
| Aveo Pharmaceuticals, INC. | $13.83 | 2024 |
Drugs and devices associated with these payments
Keytruda $429Lynparza $402Onivyde $303Tagrisso $280Jakafi $263Padcev $261Imbruvica $261Lenvima $254Kisqali $250Darzalex $221Epkinly $171Tecvayli $170Jevtana $160Scemblix $157Xtandi $156Welireg $145Monjuvi $139Reblozyl $139Nubeqa $137Verzenio $135Jaypirca $135Trodelvy $131Calquence $130Stivarga $128Vitrakvi $128Imdelltra (Amg757) $127Opdivo $126Venclexta $121Brukinsa $120Inlyta $119Ibrance $116Tukysa $116Talvey $113Doptelet $102Lonsurf $94.75Inqovi $94.75Monoferric $93.53Tecentriq $93.20Xpovio $93.09Polivy $92.89Elrexfio $92.62Libtayo $88.57Pluvicto $84.17Xospata $83.18Somatuline Depot $81.96Fruzaqla $80.49Tivdak $80.01Tibsovo $79.48Ayvakit $78.88Lunsumio $77.39Carvykti $76.37Pemazyre $72.73Rybrevant $69.57Vonjo $64.72Krazati $64.37Tazverik $61.95Clonoseq $60.68Enhertu $60.57Alecensa $59.50Rozlytrek $59.50Avastin $59.50Lorbrena $56.88Sarclisa $55.15Ultomiris $54.51Piqray $54.05Itovebi $51.40Orgovyx $51.12Vpriv $50.52Xofigo $49.94Talzenna $49.92Adcetris $49.56Imfinzi $48.70Beleodaq $48.52Danziten $48.28Vivimusta $48.28Zynyz $47.98Opdualag $45.06Camcevi $44.64Bavencio $43.44Qinlock $42.32Columvi $40.40Retevmo $39.63Mi Cancer Seek $39.61Amtagvi $39.38Tasigna $36.68Nerlynx $36.10Optune Lua (Novottf-200t) $35.70Pomalyst $35.66Zepzelca $35.40Paxlovid $33.65Comirnaty $33.65Optune Gio $33.42Vyloy $33.05Braftovi $32.65Sancuso $32.39Alunbrig $31.94Hyqvia $31.91Orserdu $28.41Axumin $28.10Posluma $28.10
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.